NR2F1 and Bosch-Boonstra-Schaaf optic atrophy syndrome: The first BBSOAS study, with patients selected from a cohort of individuals with CVI, finally reported loss-of-function point variants, proving once and for all the status of NR2F1 as a disease gene and its causative link with BBSOAS symptoms [1,30].